Trials / Unknown
UnknownNCT06140810
Impact of Atelectasis on RVEDP Following Orthotropic Heart Transplantation
Impact of Atelectasis and Lung Recruitment on RVEDP Measurement in Children Undergoing Cardiac Catheterization for Surveillance Following Orthotropic Heart Transplantation
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (estimated)
- Sponsor
- Baylor College of Medicine · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Following orthoptopic heart transplantation (OHT), children undergo surveillance cardiac catheterizations to assess for signs of rejection including muscle biopsy as well as pressure measurements to guide post transplant treatment regiments. These procedures are done under general anesthesia which promotes lung tissue collapse (atelectasis). What is not known is the effect of atelectasis on intracardiac pressures which are a critical area of monitoring post-transplant patients for rejection.
Detailed description
Following orthoptopic heart transplantation (OHT), children undergo surveillance cardiac catheterizations to assess for signs of rejection including muscle biopsy as well as pressure measurements. These procedures are done under general anesthesia which promotes lung tissue collapse (atelectasis). Atalectaisis is known to alter intra-thoracic pressures and cardiac loading conditions. What is not known is the effect of atelectasis on intracardiac pressures which are a critical area of monitoring post-transplant patients for rejection. Therefore, the aim of this study is to identify if atelectasis impacts the pressure measurements obtained during cardiac catheterization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Lung Recruitment | Lung Recruitment will be performed during general anesthesia to reduce areas of atelectasis |
Timeline
- Start date
- 2023-11-20
- Primary completion
- 2024-11-01
- Completion
- 2024-11-01
- First posted
- 2023-11-20
- Last updated
- 2023-12-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06140810. Inclusion in this directory is not an endorsement.